These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 17395591)

  • 21. Isolation of two forms of decay-accelerating factor (DAF) from human urine.
    Nakano Y; Sugita Y; Ishikawa Y; Choi NH; Tobe T; Tomita M
    Biochim Biophys Acta; 1991 Jul; 1074(2):326-30. PubMed ID: 1712233
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Kaposi's sarcoma-associated herpesvirus complement control protein mimics human molecular mechanisms for inhibition of the complement system.
    Mark L; Lee WH; Spiller OB; Proctor D; Blackbourn DJ; Villoutreix BO; Blom AM
    J Biol Chem; 2004 Oct; 279(43):45093-101. PubMed ID: 15304516
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interactions of decay-accelerating factor (DAF) with haemagglutinating human enteroviruses: utilizing variation in primate DAF to map virus binding sites.
    Williams DT; Chaudhry Y; Goodfellow IG; Lea S; Evans DJ
    J Gen Virol; 2004 Mar; 85(Pt 3):731-738. PubMed ID: 14993659
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Complement therapeutics meets nanomedicine: overcoming human complement activation and leukocyte uptake of nanomedicines with soluble domains of CD55.
    Gifford G; Vu VP; Banda NK; Holers VM; Wang G; Groman EV; Backos D; Scheinman R; Moghimi SM; Simberg D
    J Control Release; 2019 May; 302():181-189. PubMed ID: 30974134
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Purification and functional analysis of the polymorphic variants of the C3b/C4b receptor (CR1) and comparison with H, C4b-binding protein (C4bp), and decay accelerating factor (DAF).
    Seya T; Holers VM; Atkinson JP
    J Immunol; 1985 Oct; 135(4):2661-7. PubMed ID: 3161944
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The mechanism of action of decay-accelerating factor (DAF). DAF inhibits the assembly of C3 convertases by dissociating C2a and Bb.
    Fujita T; Inoue T; Ogawa K; Iida K; Tamura N
    J Exp Med; 1987 Nov; 166(5):1221-8. PubMed ID: 2445886
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Complement alternative pathway activation and control on membranes of human lymphoid B cell lines.
    Caudwell V; Porteu F; Calender A; Pangburn MK; Halbwachs-Mecarelli L
    Eur J Immunol; 1990 Dec; 20(12):2643-50. PubMed ID: 1702720
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distinct CD55 Isoform Synthesis and Inhibition of Complement-Dependent Cytolysis by Hepatitis C Virus.
    Kwon YC; Kim H; Meyer K; Di Bisceglie AM; Ray R
    J Immunol; 2016 Aug; 197(4):1127-36. PubMed ID: 27357152
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Segment spanning residues 727-768 of the complement C3 sequence contains a neoantigenic site and accommodates the binding of CR1, factor H, and factor B.
    Becherer JD; Alsenz J; Esparza I; Hack CE; Lambris JD
    Biochemistry; 1992 Feb; 31(6):1787-94. PubMed ID: 1371073
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hybrid proteins of Cobra Venom Factor and cobra C3: tools to identify functionally important regions in Cobra Venom Factor.
    Hew BE; Wehrhahn D; Fritzinger DC; Vogel CW
    Toxicon; 2012 Sep; 60(4):632-47. PubMed ID: 22609532
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Generation of a novel decay accelerating factor (DAF) knock-out rat model using clustered regularly-interspaced short palindromic repeats, (CRISPR)/associated protein 9 (Cas9), genome editing.
    Detsika MG; Goudevenou K; Geurts AM; Gakiopoulou H; Grapsa E; Lianos EA
    Transgenic Res; 2021 Feb; 30(1):11-21. PubMed ID: 33387103
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Release of decay-accelerating factor (DAF) from the cell membrane by phosphatidylinositol-specific phospholipase C (PIPLC). Selective modification of a complement regulatory protein.
    Davitz MA; Low MG; Nussenzweig V
    J Exp Med; 1986 May; 163(5):1150-61. PubMed ID: 2422313
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Crystal structure and mutational analysis of the DaaE adhesin of Escherichia coli.
    Korotkova N; Le Trong I; Samudrala R; Korotkov K; Van Loy CP; Bui AL; Moseley SL; Stenkamp RE
    J Biol Chem; 2006 Aug; 281(31):22367-22377. PubMed ID: 16751628
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of a hybrid complement regulatory protein, membrane cofactor protein decay accelerating factor on Chinese hamster ovary. Comparison of its regulatory effect with those of decay accelerating factor and membrane cofactor protein.
    Iwata K; Seya T; Ariga H; Nagasawa S
    J Immunol; 1994 Apr; 152(7):3436-44. PubMed ID: 7511647
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mapping of epitopes, glycosylation sites, and complement regulatory domains in human decay accelerating factor.
    Coyne KE; Hall SE; Thompson S; Arce MA; Kinoshita T; Fujita T; Anstee DJ; Rosse W; Lublin DM
    J Immunol; 1992 Nov; 149(9):2906-13. PubMed ID: 1383332
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Localization of classical and alternative pathway regulatory activity within the decay-accelerating factor.
    Brodbeck WG; Liu D; Sperry J; Mold C; Medof ME
    J Immunol; 1996 Apr; 156(7):2528-33. PubMed ID: 8786315
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Co-expression of human complement regulatory proteins DAF and MCP with an IRES-mediated dicistronic mammalian vector enhances their cell protective effects.
    Xu L; Zhao Z; Sheng J; Zhu C; Liu H; Jiang D; Mao X; Guo M; Li W
    Biochemistry (Mosc); 2008 Sep; 73(9):1025-30. PubMed ID: 18976220
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure/function of C5 convertases of complement.
    Rawal N; Pangburn MK
    Int Immunopharmacol; 2001 Mar; 1(3):415-22. PubMed ID: 11367526
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Purification and characterization of decay-accelerating factor (DAF) from Raji cells.
    Fujita T; Shinkai Y; Inoue T; Tamura N
    Immunology; 1988 Jul; 64(3):369-74. PubMed ID: 2457546
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distal recognition site for classical pathway convertase located in the C345C/netrin module of complement component C5.
    Sandoval A; Ai R; Ostresh JM; Ogata RT
    J Immunol; 2000 Jul; 165(2):1066-73. PubMed ID: 10878385
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.